|
Having trouble viewing this email? View it as a Web page.
The Food and Drug Administration (FDA) reported a shortage of doxycycline on January 18, 2013. Doxycycline is a recommended therapy for some sexually transmitted infections and syndromes including chlamydia, nongonococcal urethritis, epididymitis and pelvic inflammatory disease and as an alternative treatment for syphilis in patients with a penicillin allergy. For more information and alternative treatment regimens, view Doxycycline Shortage You received this email because you are subscribed to the STD Treatment page on the CDC web site. To change your subscription preferences, use the links below. Modify/Update Subscriber Preferences | Unsubscribe | Send Feedback | Learn more about CDC Email Updates To receive the latest news for your region, please update your profile with your country, state and zip code. Questions or problems? Please contact support@xxxxxxxxxxxxxxx.
|
||||||||||||||||||||||||||||||||||
